Čájehuvvojit 61 - 80 oktiibuot 3 961 bohtosis ohcui ((((clarifications OR clarifications) OR modification) OR modifications) OR notification)', ohcanáigi: 0,18s Aiddostahte ozu
  1. 61
  2. 62

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles Dahkki Laxmi Pandey (18762706)

    Almmustuhtton 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  3. 63

    Uncovering hidden protein modifications with native top-down mass spectrometry Dahkki Jack L. Bennett (19428651)

    Almmustuhtton 2025
    Fáttát: “…post-translational modifications…”
  4. 64
  5. 65

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles Dahkki Laxmi Pandey (18762706)

    Almmustuhtton 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  6. 66

    Functional impact of PG modifications on colony opacity of <i>S. pneumoniae.</i> Dahkki Xiu-Yuan Li (3328056)

    Almmustuhtton 2025
    “…<p><b>(A)</b> Illustrative depiction of the two post-synthetic PG modifications. M, <i>N</i>-acetylmuramic acid (NAM). …”
  7. 67

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles Dahkki Laxmi Pandey (18762706)

    Almmustuhtton 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  8. 68

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles Dahkki Laxmi Pandey (18762706)

    Almmustuhtton 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications Dahkki Olasunkanmi O. Olaoye (10131945)

    Almmustuhtton 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  14. 74

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications Dahkki Olasunkanmi O. Olaoye (10131945)

    Almmustuhtton 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  15. 75
  16. 76

    <b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m Dahkki Jamie Sperger (21646463)

    Almmustuhtton 2025
    “…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”
  17. 77
  18. 78

    Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in α1 Subunits. Dahkki Kieran Bhave (9234643)

    Almmustuhtton 2025
    Fáttát: “…substituted cysteine modification…”
  19. 79
  20. 80

    Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits. Dahkki Kieran Bhave (9234643)

    Almmustuhtton 2025
    Fáttát: “…substituted cysteine modification…”